A comprehensive analysis of proteins involved in innate and acquired resistance to molecularly-targeted drugs in breast cancer cells

被引：0
|
作者：
Montazeri, Hamid
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2951
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2951
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Heterogeneity and Plasticity of Human Breast Cancer Cells in Response to Molecularly-Targeted Drugs
    Bousoik, Emira
    Nabiee, Ramina
    Amirrad, Farideh
    Nichols, Ashley
    Witt, Rebecca
    Mandipoor, Parvin
    Aliabadi, Hamidreza Montazeri
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [2] Molecularly-targeted therapy for the oral cancer stem cells
    Ohnishi, Yuichi
    Yasui, Hiroki
    Nozaki, Masami
    Nakajima, Masahiro
    [J]. JAPANESE DENTAL SCIENCE REVIEW, 2018, 54 (02) : 88 - 103
  • [3] Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation
    Mashima, Tetsuo
    Ushijima, Masaru
    Matsuura, Masaaki
    Tsukahara, Satomi
    Kunimasa, Kazuhiro
    Furuno, Aki
    Saito, Sakae
    Kitamura, Masami
    Soma-Nagae, Taeko
    Seimiya, Hiroyuki
    Dan, Shingo
    Yamori, Takao
    Tomida, Akihiro
    [J]. CANCER SCIENCE, 2015, 106 (07) : 909 - 920
  • [4] Establishing a Model to Identify Mutant Subpopulations That Cause Resistance to Molecularly-Targeted Cancer Therapies.
    Banda, M.
    Mckim, K. L.
    Parsons, B. L.
    [J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2016, 57 : S75 - S75
  • [5] Establishing a Primary Lung Cancer Model to Identify Mutant Subpopulations That Cause Resistance to Molecularly-targeted Cancer Therapies.
    Banda, M.
    McKim, K. L.
    Myers, M. B.
    Parsons, B. L.
    [J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2018, 59 : 49 - 49
  • [6] Analysis of Time-to-onset of Interstitial Lung Disease after the Administration of Small Molecule Molecularly-targeted Drugs
    Komada, Fusao
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2018, 138 (02): : 229 - 235
  • [7] Oral cancer screening approach based on labeling exfoliated oral cells with molecularly-targeted optical contrast agents
    Leautaud, Veronica
    Horres, Charles R.
    Bhattar, Vijayashree S.
    Williams, Michelle D.
    Gillenwater, Ann M.
    Richards-Kortum, Rebecca R.
    [J]. PHOTONIC THERAPEUTICS AND DIAGNOSTICS VII, 2011, 7883
  • [8] Src and CXCR4 are involved in the invasiveness of breast cancer cells with acquired resistance to lapatinib
    De Luca, Antonella
    D'Alessio, Amelia
    Gallo, Marianna
    Maiello, Monica R.
    Bode, Ann M.
    Normanno, Nicola
    [J]. CELL CYCLE, 2014, 13 (01) : 148 - 156
  • [9] Discovery of Proteins Responsible for Resistance to Three Chemotherapy Drugs in Breast Cancer Cells Using Proteomics and Bioinformatics Analysis
    Cha, Hyo Kyeong
    Cheon, Seongmin
    Kim, Hyeyoon
    Lee, Kyung-Min
    Ryu, Han Suk
    Han, Dohyun
    [J]. MOLECULES, 2022, 27 (06):
  • [10] Comprehensive high-throughput screen for combination therapies to block acquired resistance to targeted drugs
    Haviv, Izhak
    [J]. CANCER RESEARCH, 2017, 77
12345